None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Group/Cohort Lable: The obese group group/Cohort Description: Obese patients (BMI =25 kg/m2) with chronic diseases such as cardiovascular disease, hypertension, diabetes, and metabolic syndrome. More than 10% of the patients in the obese group will be patients with a BMI =30. Group/Cohort Lable: The control group group/Cohort Description: Adults with BMI 18.5~24.9 kg/m2.
Exclusion criteria
Exclusion criteria: Criteria for excluding normal groups 1. Severe non-cardiovascular disease with a life expectancy of 6 months or less 2. Pregnant women or pregnant women are suspected or nursing 3. Those who are continuously taking medications prescribed by doctors for chronic diseases other than hypertension and dyslipidemia; 4. Within 5 years of being diagnosed with a malignant tumor 5. Those who have difficulty using smartphones Criteria for excluding obesity groups 1. Serious non-cardiovascular disease with a life expectancy of 6 months or less 2. Pregnant women or pregnant women suspected or nursing 3. Patients within 3 months of organ transplantation 4. Patients currently being treated for acute rejection of transplantation 5. Patients treated for acute coronary syndrome (myocardial infarction, unstable angina) and within 6 months of discharge 6. Patients treated in hospital for acute cerebral infarction and within 6 months of discharge Type 1 diabetes 8. Steroid, a patient taking female hormones 9. Those who have difficulty using smartphones
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Differences of nutriomics according to obesity phenotypes | — |
Secondary
| Measure | Time frame |
|---|---|
| A composite of all-cause mortality, cardiovascular mortality, non-fatal myocardial infarction, non-fatal stroke, revascularization of coronary artery, and heart failure hospitalization. | — |
Countries
Korea, Republic of
Contacts
Yonsei University Health System, Severance Hospital